Joshua J. Field, M.D.

Original Publications

• Frei-Jones MJ, Field JJ, DeBaun MR
  Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate.
  Pediatr Blood Cancer 2009 Sep;53(3):401-5
• Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, Strieter RM, Linden J
  NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.
  Blood 2009 Jul 16;114(3):667-76
• Field JJ, Madadi AR, Siegel MJ, Narra V
  Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity.
  Am J Hematol 2009 Jul 6;84(10):686-688
• Knight-Perry JE, Field JJ, Debaun MR, Stocks J, Kirkby J, Strunk RC
  Hospital admission for acute painful episode following methacholine challenge in an adolescent with sickle cell disease.
  Pediatr Pulmonol 2009 Jun 5;44(7):728-730
• Ling HT, Field JJ, Blinder MA
  Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
  Am J Hematol 2009 Jul;84(7):418-21
• Field JJ, Strunk RC, Knight-Perry JE, Blinder MA, Townsend RR, DeBaun MR
  Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
  Am J Hematol 2009 Apr;84(4):231-3
• Field JJ, Krings J, White NL, Yan Y, Blinder MA, Strunk RC, Debaun MR
  Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease.
  Am J Hematol 2009 Mar;84(3):158-60
• Frei-Jones MJ, Field JJ, DeBaun MR
  Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.
  Pediatr Blood Cancer 2009 Apr;52(4):481-5
• Field JJ, Macklin EA, Yan Y, Strunk RC, DeBaun MR
  Sibling history of asthma is a risk factor for pain in children with sickle cell anemia.
  Am J Hematol 2008 Nov;83(11):855-7
• Strunk RC, Brown MS, Boyd JH, Bates P, Field JJ, DeBaun MR
  Methacholine challenge in children with sickle cell disease: a case series.
  Pediatr Pulmonol 2008 Sep;43(9):924-9
• Field JJ, DeBaun MR, Yan Y, Strunk RC
  Growth of lung function in children with sickle cell anemia.
  Pediatr Pulmonol 2008 Nov;43(11):1061-6
• Jennings JE, Ramkumar T, Mao J, Boyd J, Castro M, Field JJ, Strunk RC, Debaun MR
  Elevated urinary leukotriene E(4) levels are associated with hospitalization for pain in children with sickle cell disease.
  Am J Hematol 2008 Mar 26;83(8):640-643
• Field JJ, Austin PF, An P, Yan Y, DeBaun MR
  Enuresis is a common and persistent problem among children and young adults with sickle cell anemia.
  Urology 2008 Jul;72(1):81-4
• Field JJ, Glassberg J, Gilmore A, Howard J, Patankar S, Yan Y, Davies SC, Debaun MR, Strunk RC
  Longitudinal analysis of pulmonary function in adults with sickle cell disease.
  Am J Hematol 2008 Jul;83(7):574-6
• Du HY, Pumbo E, Manley P, Field JJ, Bayliss SJ, Wilson DB, Mason PJ, Bessler M
  Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.
  Blood 2008 Feb 1;111(3):1128-30
• Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, Field JJ
  Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay.
  Pediatr Blood Cancer 2008 Mar;50(3):603-6
• Field JJ, Fenske TS, Blinder MA
  Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
  Haemophilia 2007 Jan;13(1):46-50
• Field JJ, Giannone L, Bessler M, Blinder MA
  Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failure.
  Pharmacotherapy 2006 Nov;26(11):1662-6
• Field JJ, Mason PJ, An P, Kasai Y, McLellan M, Jaeger S, Barnes YJ, King AA, Bessler M, Wilson DB
  Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
  J Pediatr Hematol Oncol 2006 Jul;28(7):450-3